Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications
- PMID: 28871254
- PMCID: PMC5566570
- DOI: 10.3389/fimmu.2017.00977
Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications
Abstract
With just three CDRs in their variable domains, the antigen-binding site of camelid heavy-chain-only antibodies (HcAbs) has a more limited structural diversity than that of conventional antibodies. Even so, this does not seem to limit their specificity and high affinity as HcAbs against a broad range of structurally diverse antigens have been reported. The recombinant form of their variable domain [nanobody (Nb)] has outstanding properties that make Nbs, not just an alternative option to conventional antibodies, but in many cases, these properties allow them to reach analytical or diagnostic performances that cannot be accomplished with conventional antibodies. These attributes include comprehensive representation of the immune specificity in display libraries, easy adaptation to high-throughput screening, exceptional stability, minimal size, and versatility as affinity building block. Here, we critically reviewed each of these properties and highlight their relevance with regard to recent developments in different fields of immunosensing applications.
Keywords: VHH; haptens; imaging; immunodetection; nanobodies; phage display.
Figures






Similar articles
-
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.Curr Pharm Des. 2016;22(43):6500-6518. doi: 10.2174/1381612822666160923114417. Curr Pharm Des. 2016. PMID: 27669966 Review.
-
Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.J Nanobiotechnology. 2015 May 6;13:33. doi: 10.1186/s12951-015-0091-7. J Nanobiotechnology. 2015. PMID: 25944262 Free PMC article.
-
A guide to: generation and design of nanobodies.FEBS J. 2021 Apr;288(7):2084-2102. doi: 10.1111/febs.15515. Epub 2020 Aug 28. FEBS J. 2021. PMID: 32780549 Free PMC article. Review.
-
Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.Biochim Biophys Acta. 2015 Jul;1850(7):1397-404. doi: 10.1016/j.bbagen.2015.03.009. Epub 2015 Mar 26. Biochim Biophys Acta. 2015. PMID: 25819371 Free PMC article.
-
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Front Immunol. 2017 Nov 22;8:1603. doi: 10.3389/fimmu.2017.01603. eCollection 2017. Front Immunol. 2017. PMID: 29213270 Free PMC article. Review.
Cited by
-
Molecular basis for thermal stability and affinity in a VHH: Contribution of the framework region and its influence in the conformation of the CDR3.Protein Sci. 2022 Nov;31(11):e4450. doi: 10.1002/pro.4450. Protein Sci. 2022. PMID: 36153698 Free PMC article.
-
Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control.Metab Eng. 2024 Sep;85:116-130. doi: 10.1016/j.ymben.2024.07.012. Epub 2024 Jul 24. Metab Eng. 2024. PMID: 39059674 Free PMC article.
-
Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice.Front Immunol. 2018 Sep 25;9:2202. doi: 10.3389/fimmu.2018.02202. eCollection 2018. Front Immunol. 2018. PMID: 30319646 Free PMC article.
-
Selection and Characterization of CSFV-Specific Single-Domain Antibodies and Their Application along with Immunomagnetic Nanobeads and Quantum Dots.Biomed Res Int. 2020 Jan 30;2020:3201630. doi: 10.1155/2020/3201630. eCollection 2020. Biomed Res Int. 2020. PMID: 32090077 Free PMC article.
-
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.J Virol. 2018 Aug 29;92(18):e00837-18. doi: 10.1128/JVI.00837-18. Print 2018 Sep 15. J Virol. 2018. PMID: 29950421 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous